You’re cruising through a GI pharm block when a seemingly “easy” question on antacids pops up—until you realize every answer choice is a trap for a different concept (drug interactions, renal failure, acid rebound, and timing). These are the questions that separate “I’ve heard of Tums” from “I can predict the adverse effect in a patient with CKD.” Let’s break one down the way Q-banks expect you to think: pick the best answer, then explain why every distractor is wrong (or right in a different patient).
Tag: GI > GI Pharmacology
The Vignette (Q-bank style)
A 68-year-old man with chronic kidney disease (CKD stage 4) and osteoarthritis comes to clinic for burning epigastric pain after meals. He has been self-treating with an over-the-counter medication for “heartburn” several times per day for the past 2 weeks. He now reports progressive fatigue and proximal muscle weakness. Labs show:
- Calcium: 9.2 mg/dL (normal)
- Magnesium: 3.1 mg/dL (elevated)
- Creatinine: 3.2 mg/dL (baseline 3.0)
Which OTC medication is most likely responsible?
A. Calcium carbonate
B. Aluminum hydroxide
C. Magnesium hydroxide
D. Bismuth subsalicylate
E. Omeprazole
Step 1: Identify the Tested Concept
This question is really asking:
- Which antacid component causes hypermagnesemia, especially in renal failure?
In CKD, the kidneys can’t excrete magnesium well. Magnesium-containing antacids (and laxatives) can therefore cause hypermagnesemia, leading to neuromuscular depression (weakness, lethargy), hypotension, bradycardia, and in severe cases arrhythmias.
Correct Answer: C. Magnesium hydroxide
Why it’s correct
Magnesium hydroxide is a classic antacid (also used as a laxative). In patients with renal insufficiency, magnesium can accumulate → hypermagnesemia.
High-yield clinical effects of hypermagnesemia
- Weakness, decreased deep tendon reflexes
- Lethargy, confusion
- Hypotension, bradycardia
- ECG changes/arrhythmias (severe)
High-yield Step correlations
- Magnesium-containing antacids/laxatives: avoid or use cautiously in CKD
- Think “Mg = muscle relaxation” (physiology crossover): too much Mg depresses neuromuscular function.
Now Destroy the Distractors (One by One)
A. Calcium carbonate — Not this vignette
Calcium carbonate (e.g., Tums) is a common antacid.
What it actually causes (classic boards):
- Hypercalcemia
- Milk-alkali syndrome: hypercalcemia, metabolic alkalosis, and renal impairment
- Historically from lots of milk + absorbable alkali; now can happen with excessive calcium carbonate
- Constipation
- Can increase risk of kidney stones in susceptible patients
Why it’s wrong here:
- Patient’s calcium is normal
- Symptoms/labs point to hypermagnesemia, not hypercalcemia
USMLE pearl: Calcium carbonate is absorbable → systemic effects (hypercalcemia, alkalosis) show up in vignettes.
B. Aluminum hydroxide — Wrong, but important
Aluminum hydroxide is an antacid that can cause issues in CKD too—but different ones.
What it causes:
- Constipation
- Hypophosphatemia (aluminum binds phosphate in the gut)
- Can lead to bone pain, osteomalacia, muscle weakness over time
- In renal failure: risk of aluminum toxicity (encephalopathy, bone disease) with chronic exposure
Why it’s wrong here:
- The lab abnormality is high magnesium, not low phosphate
- Timeline is short (2 weeks); aluminum-related bone effects are usually more chronic
- Classic aluminum clue is constipation + hypophosphatemia
USMLE pearl:
- Aluminum binds phosphate → hypophosphatemia.
- Magnesium causes diarrhea (opposite of aluminum).
D. Bismuth subsalicylate — Different drug class, different toxicities
Bismuth subsalicylate (e.g., Pepto-Bismol) is not an antacid; it’s used for dyspepsia and diarrhea and has antimicrobial effects (including activity against H. pylori regimens historically).
What it causes:
- Black tongue and black stools (benign, common)
- Salicylate toxicity risk if overused (especially kids, renal disease, anticoagulated patients)
- Avoid in children/teens with viral illness due to Reye syndrome risk (salicylate association)
Why it’s wrong here:
- Doesn’t explain hypermagnesemia
- Would expect dark stools/tongue or salicylate-related symptoms (tinnitus, hyperventilation, mixed acid-base disorder)
E. Omeprazole — Not OTC “antacid” toxicity; wrong timeline and labs
Omeprazole is a proton pump inhibitor (PPI), not an antacid. It irreversibly inhibits the H⁺/K⁺ ATPase in parietal cells.
High-yield adverse effects (especially with long-term use):
- C. difficile infection
- Pneumonia (early association; boards sometimes test it)
- Hypomagnesemia (yes—PPIs can lower Mg)
- Vitamin B12 deficiency
- Decreased calcium absorption → fractures (esp. older patients)
- Possible acute interstitial nephritis (AIN) (think: fever, rash, eosinophilia—though classic triad is often incomplete)
Why it’s wrong here:
- The patient has hypermagnesemia, not hypo-
- Presentation is tied to OTC antacid overuse and CKD magnesium retention
The Core Antacid Table (Memorize This)
| Agent (OTC/common) | Key adverse effect(s) | Acid-base / lab clue | Other board-relevant notes |
|---|---|---|---|
| Magnesium hydroxide | Diarrhea, hypermagnesemia (esp. CKD) | ↑Mg | Neuromuscular depression in severe cases |
| Aluminum hydroxide | Constipation, hypophosphatemia | ↓Phos | Phosphate binding; aluminum toxicity risk in CKD |
| Calcium carbonate | Constipation, hypercalcemia, milk-alkali syndrome | ↑Ca, metabolic alkalosis | Absorbable; kidney stones risk |
| Sodium bicarbonate | Metabolic alkalosis, belching | Metabolic alkalosis | “Absorbable antacid,” can cause volume overload (Na load) |
High-Yield “Why Every Answer Choice Matters” Concepts
1) Antacids mess with absorption (timing matters)
Antacids can reduce absorption of certain drugs via chelation or altered gastric pH. Commonly tested interactions:
- Tetracyclines
- Fluoroquinolones
- Iron
- Levothyroxine (real-world common)
- Azole antifungals (need acidic environment for absorption—more often tested with PPIs/H2 blockers but can show up)
Test-taking move: If the stem includes “takes doxycycline for acne” or “on ciprofloxacin,” scan for antacid/metal cation interactions and timing (separate by hours).
2) CKD changes what’s “safe OTC”
- Magnesium and aluminum can accumulate in renal failure.
- Q-banks love: “He has CKD and is taking an OTC antacid/laxative—what electrolyte abnormality?”
3) Quick symptom pattern recognition
- Diarrhea → magnesium
- Constipation → aluminum or calcium
- Hypercalcemia + alkalosis → calcium carbonate (milk-alkali)
- Hypophosphatemia → aluminum
- Black stools/tongue → bismuth
Rapid-Fire Practice (Mini Checks)
- CKD + antacid + weakness + ↑Mg → magnesium hydroxide
- Constipation + ↓phosphate → aluminum hydroxide
- Hypercalcemia + metabolic alkalosis → calcium carbonate
- Black stool + dyspepsia OTC → bismuth subsalicylate
- Chronic acid suppression + C. diff risk → PPI
Takeaway
Antacids are “simple” until the question adds kidney disease, electrolytes, constipation vs diarrhea, phosphate binding, or drug absorption. When you see an OTC GI med in a vignette, don’t just pick the one you recognize—map it to a signature adverse effect + a patient context (especially CKD), and you’ll start getting these right consistently.